Dr. Reddy's Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana, India. It was founded by Anji Reddy in 1984 and has since grown to become one of the leading generic and specialty pharmaceutical companies globally.

The company operates in more than 20 countries worldwide with a strong presence in markets such as the United States, Europe, Russia, CIS countries, India, and other emerging markets. Dr. Reddy's focuses on developing high-quality medicines across various therapeutic areas including oncology, cardiovascular diseases, dermatology, gastroenterology, pain management, anti-infectives, etc.

Dr. Reddy's Laboratories is known for its innovative research and development efforts which have resulted in several groundbreaking products that have helped improve patient outcomes around the world. The company also invests heavily in technologies like continuous manufacturing to enhance efficiency and reduce time-to-market for its products.

One of the key factors that make Dr. Reddy's stand out from its competitors is its commitment to quality and affordability. The company constantly strives to provide cost-effective yet high-quality medications to patients globally while maintaining stringent adherence to regulatory standards.

In terms of collaborations and partnerships, Dr. Reddy’s has forged strategic alliances with global pharma giants like GlaxoSmithKline (GSK) for co-developing complex generics as well as AstraZeneca for commercializing certain drugs across select emerging markets.